Outcome of axillary staging in early breast cancer: A meta-analysis

Breast Cancer Research and Treatment

Volumn 120, Issue 2, 2010, Pages 441-447

  Kell, Malcolm R ^a   Burke, John P ^a   Barry, Mitchel ^a   Morrow, Monica ^b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Axillary; Lymphadenectomy outcome; Morbidity; Sentinel

Indexed keywords

ARM EDEMA; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; DIAGNOSTIC PROCEDURE; EARLY CANCER; HUMAN; INFECTION RISK; INTERMETHOD COMPARISON; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MORBIDITY; PARESTHESIA; PRIORITY JOURNAL; SENTINEL LYMPH NODE BIOPSY; SEROMA;

BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; NEOPLASM STAGING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SENTINEL LYMPH NODE BIOPSY;

EID: 77950692261     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0705-6     Document Type: Article

References (26)

1. Burke JP, Power C, Gorey TF et al (2008) A comparative study of risk factors and prognostic features between symptomatic and screen detected breast cancer. Eur J Surg Oncol 34(2): 149-153
2. Kell MR, Kerin MJ (2004) Sentinel lymph node biopsy. BMJ 328(7452): 1330-1331
3. 3. Veronesi U, Paganelli. G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349(6):546-553 (Pubitemid 36951366)
4. 4. Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98(9):599-609 (Pubitemid 43904843)
5. Lau J, Ioannidis JP, Schmid CH (1997) Quantitative synthesis in systematic reviews. Ann Intern Med 127(9):820-826
6. www.clinical.trials.gov
7. 7. Purushotham AD, Upponi S, Klevesath MB et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23(19):4312-4321 (Pubitemid 46209968)
8. 8. Lucci A, McCall LM, Beitsch PD et al (2007) Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group trial ZOO11. J Clin Oncol 25(24):3657-3663 (Pubitemid 47372604)
9. 9. Zavagno G, De Salvo GL, Scalco G et al (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247(2):207-213 (Pubitemid 351156760)
10. Krag DN, Anderson SJ, Julian TB et al (2007) Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically nodenegative breast cancer: results from the NSABP B-32 randomised phase III trial. Lancet Oncol 8(10):881-888
11. Gill G (2009) Sentinel-lymph-node-based management or routine axillary clearance? One-year outcomes of sentinel node biopsy versus axillary clearance (SNAC): a randomized controlled surgical trial. Ann Surg Oncol 16(2):266-275
12. Krag DN, Julian TB, Harlow SP et al (2004) NSABP-32: phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: a description of the trial. Ann Surg Oncol 11(3Suppl):208S-210S
13. Tewari N, Gill PG, Bochner MA, Kollias J (2008) Comparison of volume displacement versus circumferential arm measurements for lymphoedema: implications for the SNAC trial. ANZ J Surg 78(10):889-893
14. 14. Petrek JA, Senie RT, Peters M, Rosen PP (2001) Lymphedema in a cohort of breast carcinoma survivors 20 years after diagnosis. Cancer 92(6): 1368-1377 (Pubitemid 32947819)
15. 15. Meric F, Buchholz TA, Mirza NQ et al (2002) Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 9(6):543-549 (Pubitemid 34774414)
16. 16. Silberman AW, McVay C, Cohen JS et al (2004) Comparative morbidity of axillary lymph node dissection and the sentinel lymph node technique: implications for patients with breast cancer. Ann Surg 240(1): 1-6 (Pubitemid 38808226)
17. Maaskant AJ, van de Poll-Franse LV, Voogd AC et al (2009) Stage migration due to introduction of the sentinel node procedure: a population-based study. Breast Cancer Res Treat 113(1): 173-179
18. 18. Classe JM, Curtet C, Campion L et al (2003) Learning curve for the detection of axillary sentinel lymph node in breast cancer. Eur J Surg Oncol 29(5):426-433 (Pubitemid 36748584)
19. Fleissig A, Fallowfield LJ, Langridge CI et al (2006) Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95(3):279-293
20. Wilke LG, McCall LM, Posther KE et al (2006) Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13(4):491-500
21. McLaughlin SA, Wright MJ, Morris KT et al (2008) Prevalence of lymphedema in women with breast cancer 5 years after sentinel lymph node biopsy or axillary dissection: objective measurements. J Clin Oncol 26(32):5213-5219
22. Erickson VS, Pearson ML, Ganz PA et al (2001) Arm edema in breast cancer patients. J Natl Cancer Inst 93(2):96-111
23. Giuliano AE, Haigh PI, Brennan MB et al (2000) Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18(13):2553-2559
24. Goyal A, Newcombe RG, Chhabra A, Mansel RE (2008) Morbidity in breast cancer patients with sentinel node metastases undergoing delayed axillary lymph node dissection (ALND) compared with immediate ALND. Ann Surg Oncol 15 (1): 262-267
25. Stewart LA, Tierney JF (2002) To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 25(l):76-97
26. 26. Clarke M, Stewart L, Pignon JP, Bijnens L (1998) Individual patient data meta-analysis in cancer. Br J Cancer 77(11):20362044 (Pubitemid 28254654)